vida: research 2026 04 28 #4356

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 06:10:26 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 06:10 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 06:10 UTC*
Member
  1. Factual accuracy — The claims in the research-journal.md regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and common knowledge of recent health industry developments.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content in research-journal.md is unique, and the inbox/queue files are distinct archive metadata entries.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry details specific commercial outcomes (bankruptcy vs. profitable IPO) that strongly support the "atoms-to-bits" thesis, justifying the "SIGNIFICANTLY STRENGTHENED" assessment.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the `research-journal.md` regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and common knowledge of recent health industry developments. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content in `research-journal.md` is unique, and the `inbox/queue` files are distinct archive metadata entries. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry details specific commercial outcomes (bankruptcy vs. profitable IPO) that strongly support the "atoms-to-bits" thesis, justifying the "SIGNIFICANTLY STRENGTHENED" assessment. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes.

2. Duplicate/redundancy:
This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched or created in this PR, so there is no risk of duplicate evidence injection into existing claims.

3. Confidence:
No claims are present in this PR (only research journal and source files), so confidence calibration does not apply.

4. Wiki links:
The research journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual wiki links are present to evaluate.

5. Source quality:
The nine source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), concrete financial data (bankruptcy filings, IPO valuations, revenue figures), and payer statistics (34% employer mandate, 9M lives managed) — these are verifiable, high-quality sources appropriate for healthcare market analysis.

6. Specificity:
No claims are being added or modified in this PR (only research journal documentation), so specificity evaluation does not apply.

Overall assessment: This PR documents a research investigation session with supporting source materials. No claims or entities are being created or modified, so the primary evaluation criteria (schema for claims/entities, confidence calibration, specificity) do not apply. The research journal entry itself is well-structured, documents a clear disconfirmation attempt of Belief 4, and is supported by nine credible source files. The content is factually coherent and the sources appear credible for market analysis purposes.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes. **2. Duplicate/redundancy:** This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched or created in this PR, so there is no risk of duplicate evidence injection into existing claims. **3. Confidence:** No claims are present in this PR (only research journal and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual [[wiki links]] are present to evaluate. **5. Source quality:** The nine source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), concrete financial data (bankruptcy filings, IPO valuations, revenue figures), and payer statistics (34% employer mandate, 9M lives managed) — these are verifiable, high-quality sources appropriate for healthcare market analysis. **6. Specificity:** No claims are being added or modified in this PR (only research journal documentation), so specificity evaluation does not apply. **Overall assessment:** This PR documents a research investigation session with supporting source materials. No claims or entities are being created or modified, so the primary evaluation criteria (schema for claims/entities, confidence calibration, specificity) do not apply. The research journal entry itself is well-structured, documents a clear disconfirmation attempt of Belief 4, and is supported by nine credible source files. The content is factually coherent and the sources appear credible for market analysis purposes. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 06:11:05 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 06:11:05 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 06:12:57 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.